Webull CorpRecord Q2 revenue beat estimates
Stock futures were lower early Thursday as persistent geopolitical tensions in the Middle East drove Brent crude over $92 a barrel, reinforcing broader inflation concerns. Webull shares climbed 14% after the digital investment platform reported record Q2 revenue of $198.8M, up 51% Y/Y and 24% Q/Q, beating estimates of $180.7M, while Ultragenyx Pharmaceutical surged 12% after the FDA granted accelerated approval to Genglycos, its gene therapy for glycogen storage disease type Ia. Circle Internet Group gained 5% alongside a broader rally in crypto-linked stocks as Bitcoin climbed more than 9% to around $71K, its highest level since June 2, following the U.S. Treasury's surprise decision to double planned buybacks of longer-dated Treasuries to at least $4B per operation. Wolfspeed plunged 10% after reporting a wider-than-expected FQ4 adjusted loss of $2.26 per share, versus the $1.47 consensus, while revenue rose 24% Y/Y to $149.6M, and Coty tumbled 9% after mixed FQ4 results with LFL revenue down 1% and adjusted operating income plunging 31%.
Webull CorpRecord Q2 revenue beat estimates
Circle Internet Group, Inc.Bitcoin rally driven by Treasury buyback decision boosts crypto-linked stocks
Bullish
Coinbase Global Inc
HIVE Digital Technologies Ltd
Robinhood Markets Inc
Marathon Digital Holdings Inc
MicroStrategy Incorporated
Riot Platforms, Inc.
Coty IncMixed FQ4 results with LFL revenue down and adjusted operating income plunging
UltragenyxFDA granted accelerated approval to Genglycos gene therapy
Wolfspeed, Inc.Wider-than-expected FQ4 adjusted loss